add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Keep clopidogrel/PPI interaction in perspective; expert predicts more to come ...TheHeart.Org - - 12 hours ago The notion that you would put another drug on board that would slightly attenuate its antiplatelet effect and that would somehow register as a large signal ... DTC pharma ads could raise Medicaid costsFierceHealthcare - Nov 25, 2009 The study, which looked at state data from 1999 to 2005 for 27 state programs, found that DTC ads for antiplatelet drug Plavix (clopidogrel) seemed to be ... Lilly posts updates on Effient usageZenopa - Nov 25, 2009 Lilly's antiplatelet medicine, Effient (prasugrel), has been added as a treatment option in two clinical guideline updates, the firm has revealed. ... Cost effective heart drug listed on PBSPharmacy News - - Nov 24, 2009 Australia's 34000 Acute Coronary Syndrome (ACS) patients will have access to a new antiplatelet therapy from the 1st December when it becomes available on ... Advertising to Consumers May Raise Drug PricesU.S. News & World Report - Nov 24, 2009 ... Direct-to-consumer drug ads may contribute to higher Medicaid costs, according to a new study that examined sales of the widely used antiplatelet drug ... Accumetrics to Present at the 21st Annual Piper Jaffray Health Care ConferencePR Newswire (press release) - Nov 24, 2009 Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, P2Y12 inhibitors (eg prasugrel (Effient(TM)) and clopidogrel (Plavix)) ... Direct-to-Consumer Ads Associated With Higher Medicaid CostsScience Daily (press release) - Nov 23, 2009 24, 2009) — Direct-to-consumer advertising (DTCA) for a commonly prescribed antiplatelet drug does not appear associated with increased use, ... Good News for Bristol-Myers - Analyst BlogBenzinga - Nov 23, 2009 Plavix, the antiplatelet blood thinner indicated to reduce the risk of heart attack in patients with atherosclerosis, is the top growth driver for Bristol. ... Statin therapy should be used to reach blood cholesterol levels before adding ...HealthJockey.com - Nov 21, 2009 These lifestyle choices could perhaps focus on antiplatelet drug therapy such as taking daily aspirin if they are at high risk, observe blood pressure and ... AstraZeneca Seeks FDA ApprovalZacks.com - Nov 20, 2009 Brilinta is the first investigational antiplatelet that has demonstrated a reduction in CV death versus Plavix in ACS patients. ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
